Live
Endpoints NewsPost-Hoc Live: Jeremy Levin on biotech's existential momentEndpoints NewsOutlook says FDA will sign off on its version of Avastin for wet AMDBioPharma DiveEarly data for heart drug affirm Lilly’s billion-dollar bet on VerveBioPharma DiveLilly dives into vaccine research with 3 biotech buyoutsFierceBiotechMakary’s FDA reforms ‘continue to move forward’ despite leadership turmoilClinical OMICsGPS Tracking Upends Rural Uganda’s Schistosomiasis Transmission AssumptionsEndpoints NewsCartesian secures funding to 'accelerate' launch; Editas sells $125M in stockEndpoints NewsCan AI do scientific research? Billions chase hopes of superintelligenceBioWorldLilly buys three vaccine makers; PCSK9 base editor shows promiseBioWorldChina’s new IIT rules expected to wipe out ‘gray market’BioWorldDaewoong takes over Turn Bio’s longevity platform from HanallBioWorldTennor’s $80M Hong Kong IPO to fund antibacterial drug pipeline
Endpoints News Apr 11, 2026

More pharma dealmaking; FDA’s proposed budget; Takeda ends partnership; and more

More pharma dealmaking; FDA’s proposed budget; Takeda ends partnership; and more

Original
Body unavailable. Use the original source.